May 2, 2018 / 5:10 AM / 8 months ago

BRIEF-Targovax: Early Signal Of Efficacy In ONCOS-102 Trial In Mesothelioma

May 2 (Reuters) - Targovax ASA:

* REG-TARGOVAX ANNOUNCES EARLY SIGNAL OF EFFICACY IN ONCOS-102 TRIAL IN MESOTHELIOMA

* SAYS ENCOURAGING RESULTS FROM ITS PHASE I/II TRIAL OF ONCOS-102 IN MESOTHELIOMA Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below